Use of CA125 fluctuation during the menstrual cycle as a tool in the clinical diagnosis of endometriosis; a preliminary report
article
OA: closed
CC0
⤵ 40 in-corpus citations
AI-generated summary
This preliminary report investigated the use of CA125 fluctuations during the menstrual cycle as a diagnostic tool for endometriosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
ObjectiveTo elucidate whether endometriosis can be diagnosed clinically by assessing the differences between serum CA125 levels during menstruation and during the rest of the menstrual cycle.MethodsThe study was performed in 28 patients who underwent laparoscopy to check for pelvic causes of infertility. Patients with endometriosis were selected as the study group, and patients with normal laparoscopic findings functioned as the control group. Blood specimens were taken for CA125 determination during menstruation and during the rest of the menstrual cycle. Mean serum CA125 concentrations were compared by the two-sample t-test for between-group comparisons and the paired t-test for within-group comparisons. The receiver operating characteristic curve was applied to assess the usefulness of CA125 level changes during the menstrual cycle in the clinical diagnosis of endometriosis.ResultsThe mean CA125 concentrations of healthy women during menstruation and during the rest of the menstrual cycle were 12.2 and 10 U ml(-1), respectively. In this group, the mean CA125 concentration was an average of 22% higher during menstruation than during the rest of the menstrual cycle (P < 0.001). The patients with endometriosis showed a similar pattern to that of normal women, but the levels differed by 198.3% in these patients (P < 0.001). Mean CA125 concentrations of these patients during menstruation and in the rest of the cycle were 35.8 and 12 U ml(-1), respectively. The mean CA125 concentration during menstruation was significantly higher in patients with endometriosis than in normal women (P 0.05). ROC curve analyses set a cutoff of 83% (percentage increment of CA125 level during menstruation compared with that on days without menstrual bleeding), which gives a sensitivity of 93% and specificity of 92%, with a corresponding likelihood ratio of 11.3.ConclusionsIt may be possible to diagnose endometriosis clinically by assessment of the differences in CA125 level during menstruation as against the remainder of the menstrual cycle.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (12)
- Drastic elevation of serum CA125, CA72-4 and CA19-9 levels during menses in a patient with probable endometriosis via openalex
- Evaluation and management of women with endometriosis via openalex
- Magnetic resonance imaging characteristics of deep endometriosis via openalex
- Serum and peritoneal CA-125 levels as diagnostic test for endometriosis via openalex
- Serum CA 125 levels before, during and after treatment for endometriosis via openalex
- The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis via openalex
- Tumor markers in endometriosis via openalex
- W2401966469 via openalex
- W1764503579 via openalex
- W2397708477 via openalex
- W2401134385 via openalex
- W68554369 via openalex
Cited by (40)
- Unexpectedly high level of cancer antigen 125 (CA 125) in endometriosis: A case report 2025
- The Diagnostic Value of the CA125 and Ultrasound Combination for Endometriosis: A Retrospective Cohort Study 2025
- <span data-contrast="auto">Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review <span data-ccp-props="{"> 2024
- Development and Validation of a novel <i>in vitro</i> diagnostic test for endometriosis 2023
- Villar’s Nodule with Multifocal Endometriosis: Case Report 2023
- Development and Validation of an Endometriosis Diagnostic Method Based on Serum Biomarkers and Clinical Variables 2023
- Combined delta neutrophil index and red blood cell distribution width as a new biomarker to predict endometriosis 2023
- Research progress of CA125 in endometriosis: Teaching an old dog new tricks 2022
- Diagnostic use of CA 125 values measured on the 2nd and 14th days of the menstrual cycle in endometriosis 2022
- The Potential of Non-Invasive Biomarkers for Early Diagnosis of Asymptomatic Patients with Endometriosis 2021
- Noninvasive evaluation of ovarian endometriosis: a single-center experience 2021
- Novel diagnostic options for endometriosis – Based on the glycome and microbiome 2021
- Endometriosis screening in patients attending an IVF clinic: a proof-of-concept retrospective cohort study 2020
- Combination of noninvasive methods in diagnosis of infertile women with minimal or mild endometriosis, a retrospective study in China 2019
- New biomarkers in endometriosis 2019
- Blood biomarkers for the non-invasive diagnosis of endometriosis 2016
- Assessing brain-derived neurotrophic factor as a novel clinical marker of endometriosis 2015
- Endometriosis and possible inflammation markers 2015
- Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis 2015
- Serum Markers for the Noninvasive Diagnosis of Endometriosis 2015
- Using Symptom Scores, Lifestyle Measures and Biochemical Markers to Create a Test for Endometriosis 2014
- Association of the neutrophil-to-lymphocyte ratio and CA 125 with the endometriosis score 2014
- Endometriosis and the Enigmatic Question of Progression 2014
- Biomarker development in endometriosis 2014
- Clinical markers of endometriosis: Have we been too quick to judge? 2014
- Correlação entre os níveis de Ca-125 séricos e os achados cirúrgicos em mulheres com sintomas sugestivos de endometriose 2013
- Noninvasive Diagnosis of Moderate to Severe Endometriosis: The Platelet-Lymphocyte Ratio Cannot Be a Neoadjuvant Biomarker for Serum Cancer Antigen 125 2013
- Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study 2012
- Pelvic Endometriosis - A Survey of Knowledge and Practice Among Gynecologists Endometriose Pélvica - Enquete com Médicos Ginecologistas 2012
- Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study 2012
- Evaluation of CA-125 and soluble CD-23 in patients with pelvic endometriosis: a case-control study 2012
- Serum HE4 concentration is not dependent on menstrual cycle or hormonal treatment among endometriosis patients and healthy premenopausal women 2012
- Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2011
- Peripheral biomarkers of endometriosis: a systematic review 2010
- The clinical significance of Inca serum CA-125 in gynecological diseases 2010
- Avaliação do CA-125 e do CD-23 solúvel em pacientes com endometriose pélvica 2010
- Diagnostik der Endometriose: Neue Tests aus peripherem Blut 2008
- Endometriosis: clinical monitoring and treatment procedures in Rhesus Monkeys 2007
- Extremely elevated serum CA-125 level as a result of unruptured unilateral endometrioma: the highest value reported 2007
- Positive correlation between serum and peritoneal fluid CA-125 levels in women with pelvic endometriosis 2006
Source provenance
- europepmc
- last seen: 2026-08-23T09:30:01.253652+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:32.173627+00:00
- unpaywall
- last seen: 2026-08-23T06:29:45.520198+00:00
License: CC0
· commercial use OK